title: Scleroderma en coup de sabre treated with polymethylmethacrylate - Case report.
abstract: The scleroderma en coup de sabre is a variant of localized scleroderma that occurs preferentially in children. The disease progresses with a proliferative and inflammatory phase and later atrophy and residual deformity, which are treated with surgical techniques such as injectable fillers, transplanted or autologous fat grafting and resection of the lesion. Among the most widely used fillers is hyaluronic acid. However, there are limitations that motivate the search for alternatives, such as polymethylmethacrylate, a permanent filler that is biocompatible, non-toxic, non-mutagenic and immunologically inert. In order to illustrate its application, a case of scleroderma en coup de sabre in a 17-year-old patient, who was treated with polymethylmethacrylate with excellent aesthetic results, is reported.
authors.affiliation: Hospital Universitário Gaffrée e Guinle, Universidade Federal do Estado do Rio de Janeiro, Rio de Janeiro, RJ, Brazil.
authors.forename: Joanna Pimenta de Araujo
authors.initials: JP
authors.lastname: Franco
authors.affiliation: Hospital Universitário Gaffrée e Guinle, Universidade Federal do Estado do Rio de Janeiro, Rio de Janeiro, RJ, Brazil.
authors.forename: Márcio Soares
authors.initials: MS
authors.lastname: Serra
authors.affiliation: Hospital Universitário Gaffrée e Guinle, Universidade Federal do Estado do Rio de Janeiro, Rio de Janeiro, RJ, Brazil.
authors.forename: Ricardo Barbosa
authors.initials: RB
authors.lastname: Lima
authors.affiliation: Hospital Universitário Gaffrée e Guinle, Universidade Federal do Estado do Rio de Janeiro, Rio de Janeiro, RJ, Brazil.
authors.forename: Antônio Macedo
authors.initials: AM
authors.lastname: D'Acri
authors.affiliation: Hospital Universitário Gaffrée e Guinle, Universidade Federal do Estado do Rio de Janeiro, Rio de Janeiro, RJ, Brazil.
authors.forename: Carlos José
authors.initials: CJ
authors.lastname: Martins
mesh_terms: D000293:Adolescent; D016587:Antimutagenic Agents / Q000627:therapeutic use*; D005546:Forehead; D006801:Humans; D008297:Male; D019904:Polymethyl Methacrylate / Q000627:therapeutic use*; D015203:Reproducibility of Results; D012536:Scalp Dermatoses / Q000188:drug therapy* / Q000473:pathology; D012594:Scleroderma, Localized / Q000188:drug therapy* / Q000473:pathology; D016896:Treatment Outcome
chemical_list: D016587:Antimutagenic Agents; D019904:Polymethyl Methacrylate